Evidence map›Paper›PMID 29644334›Full record

ArticleNPJ Parkinson's disease2018

Objective measurement in routine care of people with Parkinson's disease improves outcomes.

Parisa Farzanehfar, Holly Woodrow, Michelle Braybrook, Sarah McGregor, Andrew Evans, Frank Nicklason, Malcolm Horne

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in NPJ Parkinson's disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Parisa Farzanehfar1Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3010 Australia.
Holly Woodrow1Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3010 Australia.
Michelle Braybrook1Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3010 Australia.
Sarah McGregor2Department of Neurology, St Vincent's Hospital, Fitzroy, VIC 3065 Australia.
Andrew Evans3Department of Neurology, Royal Melbourne Hospital, Parkville, VIC 3050 Australia.
Frank Nicklason4Department of Geriatric Medicine, Royal Hobart Hospital, Hobart, TAS 7000 Australia.
Malcolm Horne1Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3010 Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is common in medicine to titrate therapy according to target ranges of objectively measured parameters. Objective measurement of motor function is available for Parkinson's Disease (PD), making it possible to optimise therapy and clinical outcomes. In this study, an accelerometry based measurement and predefined target ranges were used to assess motor function in a Northern Tasmania PD cohort managed by a Movement Disorder clinic. Approximately 40% (

Identifiers

PMID29644334
PMCPMC5882961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.